We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNET
11226
CALL
VNET Group
VNET
$2.16B
$109K ﹤0.01%
18,100
-48,200
-73% -$285K
DALT
11227
DELISTED
Anfield Diversified Alternatives ETF
DALT
$109K ﹤0.01%
+12,256
New +$117K
LOV
11228
DELISTED
Spark Networks SE American Depositary Shares
LOV
$109K ﹤0.01%
34,129
-38,240
-53% -$98.9K
VLDR
11229
PUT
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$109K ﹤0.01%
113,700
-89,900
-44% -$155K
BLTS
11230
PUT
DELISTED
Bright Lights Acquisition Corp. Class A Common Stock
BLTS
$109K ﹤0.01%
11,100
-62,800
-85% -$619K
AUS.U
11231
DELISTED
Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
AUS.U
$109K ﹤0.01%
11,096
+100
+0.9% +$987
REV
11232
DELISTED
Revlon, Inc.
REV
$109K ﹤0.01%
20,106
-54,527
-73% -$299K
CRMD icon
11233
CALL
CorMedix
CRMD
$588M
$108K ﹤0.01%
26,900
+4,300
+19% +$16K
CURV icon
11234
CALL
Torrid Holdings
CURV
$219M
$108K ﹤0.01%
25,100
-75,000
-75% -$421K
GORO icon
11235
CALL
Goldgroup Mining
GORO
$207M
$108K ﹤0.01%
66,300
-7,400
-10% -$14.5K
NPCE icon
11236
Neuropace
NPCE
$507M
$108K ﹤0.01%
+21,692
New +$143K
VHC icon
11237
CALL
VirnetX Holding Corp
VHC
$62.8M
$108K ﹤0.01%
4,605
+1,095
+31% +$30.5K
PEGRW
11238
DELISTED
Project Energy Reimagined Acquisition Corp. Warrant
PEGRW
$108K ﹤0.01%
772,584
-269,723
-26% -$85.2K
GTH
11239
DELISTED
Genetron Holdings Limited ADS
GTH
$108K ﹤0.01%
21,114
-22,047
-51% -$113K
BIOC
11240
CALL
DELISTED
Biocept, Inc.
BIOC
$108K ﹤0.01%
3,817
+1,270
+50% +$57.9K
JOFFU
11241
DELISTED
JOFF Fintech Acquisition Corp. Unit
JOFFU
$108K ﹤0.01%
11,005
-1,058
-9% -$10.4K
AGEN
11242
Agenus
AGEN
$329M
$107K ﹤0.01%
2,810
-22,578
-89% -$820K
BULZ icon
11243
MicroSectors FANG & Innovation 3x Leveraged ETN
BULZ
$336M
$107K ﹤0.01%
28,046
+7,681
+38% +$55.3K
CLBT icon
11244
PUT
Cellebrite
CLBT
$2.79B
$107K ﹤0.01%
+21,000
New +$109K
KUST
11245
PUT
Kustom Entertainment Inc
KUST
$771K
0
EEX
11246
DELISTED
Emerald Holding
EEX
$107K ﹤0.01%
+26,183
New +$84.4K
ERNA icon
11247
Eterna Therapeutics
ERNA
$4.98M
$107K ﹤0.01%
28
+5
+22% +$35.9K
IHRT icon
11248
CALL
iHeartMedia
IHRT
$457M
$107K ﹤0.01%
13,500
-4,800
-26% -$64.7K
MREO
11249
PUT
Mereo BioPharma
MREO
$50.9M
$107K ﹤0.01%
+95,900
New +$74.3K
RCAT icon
11250
CALL
Red Cat Holdings
RCAT
$1.7B
$107K ﹤0.01%
52,400
+10,900
+26% +$21.7K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.